Increased IFN-γ production to the mutated KRAS peptide KLVVVGAVGVGKSAL (representing the well-described KRASG12V mutation) was observed after 3× stimulation with the autologous tumour cell-stimulated TILs compared to young TILs (Table 2A). The gene discussed is KRAS; the disease is neoplasm.